1. Dengue – An Overview Dengue Expert Advisory Group 1
Mar 31, 2015
1. Dengue – An Overview
Dengue Expert Advisory Group
1
Introduction
• Dengue Fever
• Dengue Hemorrhagic Fever
• Dengue Shock Syndrome
2
3
Dengue Virus
• Family : Flaviviridae
• Genus : Flavivirus
• Serotypes : DV1, DV2, DV3, DV4
• Enveloped virus
• 3 major proteins
• SS positive sense RNA
4Dr. S Guanasena
Viral Serotypes
• DV1
• DV2
• DV3
• DV4
• Subgroups and clades
• One or more virus types in circulation during an epidemic
5
6
7
Pathogenesis
• Virus enters blood-reticuloendothelial system and bone marrow-blood
• Incubation period 3-10 days
• Viremia for 7 days after the entry
• Immune response ONLY for the infecting serotype
8
Pathogenesis of Dengue Fever
• “Breakbone” symptoms due to adventitial and dendridic cell involvement of the marrow
• Cytopenias due to direct marrow involvement
9
Antibody Structure
10
Pathogenesis of DHF – Role of cross reactive DV antibodies
Cross reactive antibody binds to the infecting virus
Form v- ab complexes. V- ab complexes attach to cells bearing receptors for the Fc portion of the ab
Facilitates entry of the virus into these cells and the viral replication. Therefore, more cells are infected
Increased immune response & release of cytokines
11Dr. S Guanasena
Pathogenesis of DHF Role of cross reactive T cells
Cross reactive T cells reacts with dengue virus of subsequent infection. Causes activation of these T cells
Activated cross 1. Are less effectivereacting T cells in eliminating the
secondary infecting DV
2. T cell activation contribute to
disease pathogenesis
12Dr S Guanasena
Cytokines secreted from infected macrophages and endothelial cells
Pathogenesis of Leak
Cytokines secreted from activated T cells
Exaggerated Cytokine response
Endothelial dysfunction
DV specific antibody interact with the endothelium
DV infects endothelium and kills cells
13Dr. S Guanasena
? DHF a misnomerDLF
14
Thrombocytopenia
• Low production due to temporary bone marrow suppression (DV infection, effect of cytokines)
• Increased consumption (activation of coagulation system, DIC)
• Direct infection of platelets with the virus: kills platelets
• Increased destruction of platelets by activated macrophages
15Dr. S Guanasena
Bleeding
• Thrombocytopenia
• Activation of the coagulation system due to endothelial dysfunction, cytokines
• Disseminated intravascular coagulation
• Poor perfusion of GIT: can lead to mucosal bleeding
• Drugs: Steroids, NSAIDS16Dr. S Guanasena
Organ Involvement in Dengue
• Direct involvement - infection of hepatocytes or brain with the dengue virus
• Circulatory failure - poor organ perfusion
• Drugs – Paracetamol
17Dr. S Guanasena
Organ Involvement
• Like other viruses many organ involvement has been reported (myositis, pancreatitis, myocarditis etc.)
• GB syndrome
• Stevens Johnsons
• Features may vary from one year to another and one epidemic to another
18
Symptomatic to Asymptomatic Ratio
• 500:9500
19
List of Warning SignsWarrants Admission
• No clinical improvement / worsening clinical parameters
• Persistent vomiting • Severe abdominal pain• Lethargy and or restlessness• Bleeding: severe epistaxis, black stools,
hematemesis, extensive menstrual bleeding, hematuria
• Giddiness• Pale cold clammy extremities• Less / no urine output for 4 – 6 hours
20
Clinical Features – DF
• Fever > 2 and < 10 days (essential criterion)• Headache• Retro orbital pain• Myalgia• Arthralgia/ severe backache/ bone pains• Rash• Bleeding manifestations (epistaxis, hematemesis, bloody
stools, menorrhagia, hemoptysis)• Abdominal pain• Decreased urinary output despite adequate fluid intake• Irritability in infants
Tourniquet Test
22
Management Dengue Fever
• Symptomatic
• Monitoring
Highly Suggestive of DHF Confirmed DHF**
Disproportionate tachycardia
Narrowing of pulse pressure < 20 mm
CRFT > 2 secs Tender hepatomegaly (DHF likely) Haemoconcentration HCT 20% rise from baseline or rise
approaching 20% if patient already on IV fluids
Biochemistryo Serum albumin < 3.5 g/dl or 0.5
gm/dl fall during illness Non fasting serum cholesterol < 100
mg/dl or 20mg/dl fall during illness Oedematous gall bladder wall on U/S
Ascites on U/S Pleural effusions (CXR Right lateral
decubitus or chest U/S to detect minimal effusion)
** Definitive evidence of plasma leakage
25
Pulse PressureWarning if 20 or below!
• BP 120/60 Pulse Pressure =60
• BP 80/60 Pulse Pressure= 20
26
DHF and DSSNot Complications of Dengue Fever
• Dengue Hemorrhagic Fever < 5%- leak
• Dengue Shock Syndrome-big leak
27
Capillary Refill Time
28
Dengue Shock Syndrome
• Profound Shock (No BP, No Pulse)
• Decompensated Shock (feeble pulse, pulse pressure <20)
• Compensated Shock (pulse pressure 20-30)
29
Suitable Fluids in DSS
• Normal Saline
• Hemaccel
• 6% Starch
• Dextran 40 in saline
30
Convalescent Phase• Lasts 5 – 7 days.
– Good appetite– Convalescent rash– Pruritus– Heamodynamic stability– Bradycardia– Diuresis– Stabilization of HCT– Rise in WBC– Rise in platelet count.
• Management:– Maintain oral intake, antihistamines, rest,
discharge 31
Recovery
32
Misconceptions
• Platelet Transfusions
• Steroids
• Misinterpretation of low WBC/TLC
• Antibiotics
• Growth Factors
• Empiric Anti Malarials
33
Laboratory Diagnosis
• Epidemic/ Inter epidemic
• Health care worker location (field worker vs tertiary care facility)
34
35Dr. S Guanasena
36Dr. S Guanasena
Laboratory Diagnosis
• Detection of Dengue viral antigen
• Detection of the Dengue viral genome
• Isolation of the Dengue virus
• Detection of Dengue specific IgG, IgM
37Dr. S Guanasena
Dengue serology
• IgM detection (qualitative)In a suspected case of dengue, presence of
dengue IgM indicates recent infection IgM capture ELISA (blood collected after 5th
day)50% + in 3-5 day, 70% on 7th day, 100% day 10-14
• IgG detection (quantitative) Diagnostic sero-conversion is defined as a four
fold rise (or fall) in antibodies in paired sera (collected in the first 7 days & 10 – 14 days later)
HI assay / ELISA / Neutralization assay
38
Laboratory diagnostic criteria
One of the following:1. PCR + NS1 +2. Virus culture +3. IgM seroconversion in
paired sera4. IgG seroconversion in
paired sera or fourfold IgG titer increase in paired sera
One of the following:1. IgM + in a single serum
sample2. IgG + in a single serum
sample with a HI titre of 1280 or greater
ConfirmedHighly suggestive
39
40
IgG antibody - specific to the initial infecting DV serotype + cross reacting antibody
IgM antibody to the secondary infecting DV serotype
Following primary infection –
Specific antibody response + CMI (memory T cells)
Cross reactive antibody response + CMI (memory T cells)
41Dr. S Guanasena
• The WHO does not recommend serologic tests by screening method
• ELISA is the preferred mode
42